The board of directors of Tianjin TEDA Biomedical Engineering Co. Ltd. announced that the group is expected to record a significant increase in profit for the year ended December 31, 2012 as compared with that for the year ended December 31, 2011. The increase in profit is mainly attributable to the profit contributed by the new generation of active fertilizers with higher gross profit margin which was launched into the market by the group in the fourth quarter of 2012.
Tianjin TEDA Biomedical Engineering Company Limited
Equities
8189
CNE1000004H7
Agricultural Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.076 HKD | +10.14% | +11.76% | -14.61% |
1st Jan change | Capi. | |
---|---|---|
-14.61% | 16.73M | |
+1.27% | 14.72B | |
-22.00% | 13.76B | |
+9.59% | 12.96B | |
-16.74% | 9.56B | |
-11.96% | 7.84B | |
-.--% | 7.57B | |
-17.85% | 5.47B | |
+9.44% | 4.6B | |
-27.10% | 2.43B |
- Stock Market
- Equities
- 8189 Stock
- News Tianjin TEDA Biomedical Engineering Company Limited
- Tianjin TEDA Biomedical Engineering Co. Ltd. Provides Earnings Guidance for the Year Ended December 31, 2012